Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 13, 2020

Evaluation of the efficiency of serum biotinidase activity as a newborn screening test in Turkey

Mujgan Ercan ORCID logo, Emiş Deniz Akbulut, Ozlem Oz, Nurgul Ataş, Meryem Karaca and Fatma Meriç Yılmaz

Abstract

Objectives

Biotinidase Deficiency (BD) is an autosomal recessive metabolic disorder. However, the relationship between genotype and biochemical phenotype has not been completely elucidated yet. But still, some mutations are accepted to be associated with profound or partial deficiency. We aimed to evaluate the results of biochemical enzyme activity in accordance with the presence of genetic mutations and investigate the correlation between genotype and biochemical phenotype together in the study.

Methods

This retrospective study was carried out using data from medical records of 133 infants detected by the newborn screening followed by serum biotinidase activity (BA) detection with semi-quantitative colorimetric method. Mutation analysis was performed to confirm the diagnosis. In addition, the expected biochemical phenotype based on the known mutant alleles were compared with the observed biochemical phenotype.

Results

When confirmed with mutation analysis results, the diagnostic sensitivity and specificity of serum BA with spectrophotometric method was 93.1% and 95.1%, respectively. In 93.98% of the cases conformity was observed between the biochemical phenotype and the genotype. The c.1330 G>C(p.D444H) and c.470 G>A (p.Arg157His) were the most common allelic variants with frequencies of 63.69% and 33.75%, respectively.

Conclusions

The diagnostic test is supposed to have a high sensitivity to identify asymptomatic BD patients. Apparently healthy cases with almost normal enzyme activity and a variant allele in the genetic analysis were reported to present symptoms under stress conditions, which should be kept in mind. This study can be accepted as an informative report as it may contribute to the literature in terms of the allelic frequency and determination of the relation between genotype and biochemical phenotype. Also, method verification including the assessment of possible effects of non-genetic factors on BA according to the certain mutation types is warranted.


Corresponding author: Dr. Mujgan Ercan, Department of Biochemistry, Faculty of Medicine, Harran University, Mardin Yolu 22 Km Osmanbey Kampüsü, 63300 Sanliurfa, Turkey, Phone: + 90 414 318 30 00, Fax: + 90 414 318 3192, E-mail:

  1. Research funding: None declared.

  2. Author contributions: Author Ercan M, Akbulut ED, Oz O, Ataş N and Karaca M have given substantial contributions to the conception or the design of the manuscript. Ercan M and Karaca M were responsible for enzyme activity testing and for interpretation of the DBS screening testing. Oz O was responsible for the molecular analysis and for interpretation of the genetic variants. All authors have participated to drafting the manuscript, author Yılmaz FM revised it critically. All authors read and approved the final version of the manuscript.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Therrell, BL, Padilla, CD, Loeber, JG, Kneisser, I, Saadallah, A, Borrajo, GJ, et al.. Current status of newborn screening worldwide: 2015. Semin Perinatol 2015;39:171–87. https://doi.org/10.1053/j.semperi.2015.03.002.Search in Google Scholar

2. Wolf, B. Biotinidase: its role in biotinidase deficiency and biotin metabolism. J Nutr Biochem 2005;16:441–5. https://doi.org/10.1016/j.jnutbio.2005.03.024.Search in Google Scholar

3. Hymes, J, Wolf, B. Biotinidase and its roles in biotin metabolism. Clin Chim Acta 1996;255:1–11. https://doi.org/10.1016/0009-8981(96)06396-6.Search in Google Scholar

4. Wolf, B. Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have”. Genet Med 2012;14:565–75. https://doi.org/10.1038/gim.2011.6.Search in Google Scholar

5. Wolf, B, Hsia, YE, Sweetman, L, Feldman, G, Boychuk, RB, Bart, RD, et al.. Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. Pediatrics 1981;68:113–8.10.1542/peds.68.1.113Search in Google Scholar

6. Wolf, B, Heard, GS, Jefferson, LG, Proud, VK, Nance, WE, Weissbecker, KA. Clinical findings in four children with biotinidase deficiency detected through a statewide neonatal screening program. N Engl J Med 1985;313:16–9. https://doi.org/10.1056/nejm198507043130104.Search in Google Scholar

7. Wolf, B. Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metabol 2010;100:6–13. https://doi.org/10.1016/j.ymgme.2010.01.003.Search in Google Scholar

8. Zempleni, J, Hassan, YI, Wijeratne, SS. Biotin and biotinidase deficiency. Expet Rev Endocrinol Metabol 2008;3:715–24. https://doi.org/10.1586/17446651.3.6.715.Search in Google Scholar

9. Seker Yilmaz, B, Mungan, NO, Kor, D, Bulut, D, Seydaoglu, G, Öktem, M, et al.. Twenty-seven mutations with three novel pathologenic variants causing biotinidase deficiency: a report of 203 patients from the southeastern part of Turkey. J Pediatr Endocrinol Metab 2018;31:339–43. https://doi.org/10.1515/jpem-2017-0406.Search in Google Scholar

10. Neto, EC, Schulte, J, Rubim, R, Lewis, E, DeMari, J, Castilhos, C, et al.. Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations. Braz J Med Biol Res 2004;37:295–9. https://doi.org/10.1590/s0100-879x2004000300001.Search in Google Scholar

11. Borsatto, T, Sperb-Ludwig, F, Pinto, LL, Luca, GR, Carvalho, FL, Souza, CF, et al.. Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients. BMC Med Genet 2014;15:96. https://doi.org/10.1186/s12881-014-0096-3.Search in Google Scholar

12. Strovel, ET, Cowan, TM, Scott, AI, Wolf, B. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American college of medical genetics and genomics. Genet Med 2017;19. https://doi.org/10.1038/gim.2017.84.Search in Google Scholar

13. Küry, S, Ramaekers, V, Bézieau, S, Wolf, B. Clinical utility gene card for: biotinidase deficiency. Eur J Hum Genet 2012;20. https://doi.org/10.1038/ejhg.2012.28.Search in Google Scholar

14. Canda, E, Yazici, H, Er, E, Kose, M, Basol, G, Onay, H, et al.. Single center experience of biotinidase deficiency: 259 patients and six novel mutations. J Pediatr Endocrinol Metab 2018;31:917–26. https://doi.org/10.1515/jpem-2018-0148.Search in Google Scholar

15. Borsatto, T, Sperb-Ludwig, F, Lima, SE, Carvalho, MR, Fonseca, PA, CameloJrJ, et al.. Biotinidase deficiency: genotype-biochemical phenotype association in Brazilian patients. PloS One 2017;12:e0177503. https://doi.org/10.1371/journal.pone.0177503.Search in Google Scholar

16. Wiltink, RC, Kruijshaar, ME, van Minkelen, R, Onkenhout, W, Verheijen, FW, Kemper, EA, et al.. Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations. Eur J Med Genet 2016;24:1424–9. https://doi.org/10.1038/ejhg.2016.65.Search in Google Scholar

17. Procter, M, Wolf, B, Mao, R. Forty-eight novel mutations causing biotinidase deficiency. Mol Genet Metabol 2016;117:369–72. https://doi.org/10.1016/j.ymgme.2016.01.002.Search in Google Scholar

18. Wolf, B. Biotinidase deficiency. In: Adam, MP, Ardinger, HH, Pagon, RA, Wallace, SE, Bean, LJH, Stephens, K, et al.. editors. Gene reviews(®). Seattle (WA): University of Washington; 1993.10.1111/j.1749-6632.1985.tb18443.xSearch in Google Scholar

Received: 2020-06-25
Accepted: 2020-10-10
Published Online: 2020-11-13
Published in Print: 2021-01-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow